Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced Clostridium difficile-associated disease

M L Job1, N F Jacobs

  • 1Department of Pharmacy Practice, Mercer University, School of Pharmacy, Atlanta, Georgia, USA.

Drug Safety
|July 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The incidence of postoperative nausea and vomiting after caesarean section in patients with hyperemesis gravidarum: a retrospective cohort study.

International journal of obstetric anesthesia·2020
Same author

Effect of ciprofloxacin on the pharmacokinetics of multiple-dose phenytoin serum concentrations.

Therapeutic drug monitoring·1994
Same author

Antibiotic-induced diarrhea and pseudomembranous colitis.

Postgraduate medicine·1994
Same author

Use of theophylline in neonates as an aid to ventilator weaning.

Therapeutic drug monitoring·1992
Same author

Advances in outpatient antimicrobial therapy: loracarbef.

The American journal of medicine·1992
Same author

Teicoplanin nephrotoxicity: first case report.

Pharmacotherapy·1992
Same journal

Implementation Aspects of a Medicines Shortage Policy Tool: Evidence from Australia's Serious Scarcity Substitution Instruments.

Drug safety·2026
Same journal

Availability and Communication of Risk Management Strategies for Pregnancy Category X Medicines across Australian Medicine Information Sources.

Drug safety·2026
Same journal

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same journal

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Drug safety·2026
Same journal

Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan.

Drug safety·2026
Same journal

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis.

Drug safety·2026
See all related articles

Clostridium difficile-associated disease (CDAD) is a significant gastrointestinal illness often triggered by antibacterial use. Prompt diagnosis and appropriate treatment, including antibacterial discontinuation or specific therapies like metronidazole and vancomycin, are crucial for patient recovery.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Clostridium difficile is a spore-forming anaerobe causing gastrointestinal disease.
  • Antibacterial and antineoplastic agents can promote C. difficile overgrowth and toxin release.
  • Colonization rates are higher in infants and hospitalized individuals.

Purpose of the Study:

  • To review the factors contributing to Clostridium difficile-associated disease (CDAD).
  • To discuss the spectrum of illness, incidence, and treatment options for CDAD.
  • To highlight the importance of prevention strategies for CDAD.

Main Methods:

  • Literature review of studies on Clostridium difficile and CDAD.
  • Analysis of risk factors, clinical manifestations, and therapeutic interventions.

Related Experiment Videos

  • Examination of epidemiological data and prevention measures.

    • Main Results:

    • Certain antibacterials (aminopenicillins, cephalosporins, clindamycin) are high-risk agents for CDAD.
    • CDAD spectrum ranges from mild diarrhea to severe colitis, toxic megacolon, and sepsis.
    • Metronidazole and vancomycin are effective for moderate to severe CDAD; vancomycin use is limited by resistance.

    Conclusions:

    • Discontinuation of offending antibacterials is key for mild CDAD.
    • Appropriate antibacterial selection and infection control are vital for CDAD prevention.
    • Recurrent CDAD may respond to initial treatment regimens.